Best Proton-beam therapy Doctors Worldwide — TOP 23

Dr. Stephanie Lilianne E. Bolle is a radiation oncologist and Head of Radiation Oncology at the Quirónsalud Proton Therapy Center in Madrid. She has led the department since July 2024. The center is Spain’s first proton therapy facility.

MD, University of Liège (1998). Board certified in radiation oncology (2003). She is an active member of the European Society of Paediatric Oncology and works with its Brain Tumor Group and Radiation Oncology Working Group.

She has published more than 120 scientific articles on pediatric brain tumors, proton therapy, pediatric radiation doses, and complex radiotherapy. She takes part in international projects and clinical trials, including BIOMEDE 2 and HARMONIC. Her expertise includes proton therapy, pediatric oncology, CNS and skull base tumors in adults and children, sarcomas, and complex radiotherapy planning.

Dr. Solak specializes in proton-beam therapy for various cancers, trained at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Expertise in breast, testicular, ovarian, lung, and head-neck cancers
• Fellowship-trained at one of the world's leading cancer centers
• Works at Hisar Hospital Intercontinental, a specialized facility

Prof. Merimsky heads the Soft Tissue and Bone Oncology Unit at Ichilov Hospital, specializing in proton-beam therapy for complex tumor cases.

• 41 years of experience of experience in oncology and radiation therapy
• Fellowship-trained in sarcoma treatment at Institut Gustave Roussy, Paris
• ESMO faculty member for sarcoma and thoracic oncology
• Published extensively on bone and soft tissue tumors

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Prof. Bokstein leads the Neurooncology Clinic at Ichilov – specializing in advanced radiotherapy approaches like proton-beam therapy.

• Head of Neurooncology at Israel's leading medical center
• Specializes in precision radiation treatments for brain tumors
• Focuses on minimizing damage to healthy brain tissue

Specializes in proton-beam therapy for brain and nerve tumors – trained at Duke University and leads Tel Aviv Medical Center's radiation service.

• Over 22 years of experience of experience in oncology and radiation therapy
• Head of Radiation Service for Nervous System Tumors at Tel Aviv Medical Center
• Trained in advanced radiosurgery techniques at Duke University
• Member of International Association of Neuro-Oncologists and Israel Head and Neck Tumor Society

Dr. Alemdar specializes in medical oncology with advanced training at Akdeniz University, bringing deep expertise to proton-beam therapy at Medical Park Antalya.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience across top Turkish hospitals
• Extensive training from Akdeniz University Faculty of Medicine
• Works at a leading JCI-accredited hospital complex

Dr. Auala Hubert specializes in proton-beam therapy at Hadassah Medical Center, with 36 years of experience of experience in oncology and radiotherapy.

• Head of Gastrointestinal Cancer Center at Hadassah
• Board-certified in oncology and radiotherapy
• Member of Israel Society of Clinical Oncology
• Fluent in English and Hebrew for patient communication

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Professor Gul Alco specializes in proton-beam therapy at Istanbul Medipol University, bringing over 31 years of experience of radiation oncology expertise.

• Professor in Radiation Oncology at Medipol University
• Trained at Istanbul School of Medicine and Kadir Has University
• Specialized in radiation oncology since 2003
• Worked at Florence Nightingale Hospital's Radiation Oncology Department

Handled more than 30,000 PET scans and 1,000 thyroid cancer patients – Dr. Borde brings extensive nuclear medicine expertise to proton-beam therapy.

• 11 years of experience of experience in nuclear medicine
• Proficient in radioiodine & Lu-177 RN therapies
• Published papers in various medical journals

Dr. Raj Nagarkar has performed over 50,000+ cancer surgeries with a focus on breast and thoracic oncology at HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital and Royal College of Surgeons, Edinburgh
• Professor for DNB Superspecialty Surgical Oncology and Breast Surgery
• Involved in 200+ clinical trials across phases 1-3
• Specializes in improving quality of life post-treatment

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.